Literature DB >> 27833121

Calpain research for drug discovery: challenges and potential.

Yasuko Ono1, Takaomi C Saido2, Hiroyuki Sorimachi1.   

Abstract

Calpains are a family of proteases that were scientifically recognized earlier than proteasomes and caspases, but remain enigmatic. However, they are known to participate in a multitude of physiological and pathological processes, performing 'limited proteolysis' whereby they do not destroy but rather modulate the functions of their substrates. Calpains are therefore referred to as 'modulator proteases'. Multidisciplinary research on calpains has begun to elucidate their involvement in pathophysiological mechanisms. Therapeutic strategies targeting malfunctions of calpains have been developed, driven primarily by improvements in the specificity and bioavailability of calpain inhibitors. Here, we review the calpain superfamily and calpain-related disorders, and discuss emerging calpain-targeted therapeutic strategies.

Mesh:

Substances:

Year:  2016        PMID: 27833121     DOI: 10.1038/nrd.2016.212

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  284 in total

1.  Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury.

Authors:  P A Schumacher; R G Siman; M G Fehlings
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

Review 2.  Interaction of calpastatin with calpain: a review.

Authors:  Amanda Wendt; Valery F Thompson; Darrel E Goll
Journal:  Biol Chem       Date:  2004-06       Impact factor: 3.915

3.  Does the severity of the LGMD2A phenotype in compound heterozygotes depend on the combination of mutations?

Authors:  Amets Sáenz; Yasuko Ono; Hiroyuki Sorimachi; Maria Goicoechea; France Leturcq; Lorea Blázquez; Federico García-Bragado; Alberto Marina; Juan José Poza; Margarita Azpitarte; Naoko Doi; Miguel Urtasun; Jean-Claude Kaplan; Adolfo López de Munain
Journal:  Muscle Nerve       Date:  2011-11       Impact factor: 3.217

4.  Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1.

Authors:  Olaf Gross; Amir S Yazdi; Christina J Thomas; Mark Masin; Leonhard X Heinz; Greta Guarda; Manfredo Quadroni; Stefan K Drexler; Jurg Tschopp
Journal:  Immunity       Date:  2012-03-23       Impact factor: 31.745

5.  Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha.

Authors:  Y Kobayashi; K Yamamoto; T Saido; H Kawasaki; J J Oppenheim; K Matsushima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Workineh Torben; Mayeen U Alam; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; David W Carey; Darrick Carter; Steven G Reed; Afzal A Siddiqui
Journal:  Vaccine       Date:  2014-01-04       Impact factor: 3.641

7.  Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration.

Authors:  Yubin Wang; Victor Briz; Athar Chishti; Xiaoning Bi; Michel Baudry
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

8.  Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome.

Authors:  Ashani T Weeraratna; Dorothea Becker; Kristen M Carr; Paul H Duray; Kevin P Rosenblatt; Sherry Yang; Yidong Chen; Michael Bittner; Robert L Strausberg; Gregory J Riggins; Urs Wagner; Olli P Kallioniemi; Jeffrey M Trent; Patrice J Morin; Paul S Meltzer
Journal:  Oncogene       Date:  2004-03-18       Impact factor: 9.867

9.  Candida albicans Rim13p, a protease required for Rim101p processing at acidic and alkaline pHs.

Authors:  Mingchun Li; Samuel J Martin; Vincent M Bruno; Aaron P Mitchell; Dana A Davis
Journal:  Eukaryot Cell       Date:  2004-06

10.  Allosteric inhibitors of calpains: Reevaluating inhibition by PD150606 and LSEAL.

Authors:  Kristin E Low; Sarathy Karunan Partha; Peter L Davies; Robert L Campbell
Journal:  Biochim Biophys Acta       Date:  2014-09-04
View more
  99 in total

1.  Acoustic biosensors for ultrasound imaging of enzyme activity.

Authors:  Anupama Lakshmanan; Zhiyang Jin; Suchita P Nety; Daniel P Sawyer; Audrey Lee-Gosselin; Dina Malounda; Mararet B Swift; David Maresca; Mikhail G Shapiro
Journal:  Nat Chem Biol       Date:  2020-07-13       Impact factor: 15.040

2.  Potential Alzheimer's Disease Therapeutics Among Weak Cysteine Protease Inhibitors Exhibit Mechanistic Differences Regarding Extent of Cathepsin B Up-Regulation and Ability to Block Calpain.

Authors:  Heather Romine; Katherine M Rentschler; Kaitlan Smith; Ayanna Edwards; Camille Colvin; Karen Farizatto; Morgan C Pait; David Butler; Ben A Bahr
Journal:  Eur Sci J       Date:  2017-10

3.  Ranking Reversible Covalent Drugs: From Free Energy Perturbation to Fragment Docking.

Authors:  Han Zhang; Wenjuan Jiang; Payal Chatterjee; Yun Luo
Journal:  J Chem Inf Model       Date:  2019-02-27       Impact factor: 4.956

4.  Calpain inhibitor and ibudilast rescue β cell functions in a cellular model of Wolfram syndrome.

Authors:  Lien D Nguyen; Tom T Fischer; Damien Abreu; Alfredo Arroyo; Fumihiko Urano; Barbara E Ehrlich
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-06       Impact factor: 11.205

5.  Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy.

Authors:  Weidong Zhang; Adebayo J Molehin; Juan U Rojo; Justin Sudduth; Pramodh K Ganapathy; Eunjee Kim; Arif J Siddiqui; Jasmin Freeborn; Souad R Sennoune; Jordan May; Samra Lazarus; Catherine Nguyen; Whitni K Redman; Gul Ahmad; Workineh Torben; Souvik Karmakar; Loc Le; Kameswara R Kottapalli; Pratibha Kottapalli; Roman F Wolf; James F Papin; David Carey; Sean A Gray; Jenn D Bergthold; Raymond T Damian; Bryan T Mayer; Florian Marks; Steven G Reed; Darrick Carter; Afzal A Siddiqui
Journal:  Ann N Y Acad Sci       Date:  2018-08       Impact factor: 5.691

Review 6.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

7.  Susceptibility of promastigotes and intracellular amastigotes from distinct Leishmania species to the calpain inhibitor MDL28170.

Authors:  Pedro Soares de Sousa Araújo; Simone Santiago Carvalho de Oliveira; Claudia Masini d'Avila-Levy; André Luis Souza Dos Santos; Marta Helena Branquinha
Journal:  Parasitol Res       Date:  2018-05-04       Impact factor: 2.289

Review 8.  Emerging roles of calpain proteolytic systems in macrophage cholesterol handling.

Authors:  Takuro Miyazaki; Akira Miyazaki
Journal:  Cell Mol Life Sci       Date:  2017-04-21       Impact factor: 9.261

9.  Mitigating the Metabolic Liability of Carbonyl Reduction: Novel Calpain Inhibitors with P1' Extension.

Authors:  Andreas Kling; Katja Jantos; Helmut Mack; Wilfried Hornberger; Gisela Backfisch; Yanbin Lao; Marjoleen Nijsen; Beatrice Rendenbach-Mueller; Achim Moeller
Journal:  ACS Med Chem Lett       Date:  2018-02-04       Impact factor: 4.345

10.  Calcium-Activated Calpain Specifically Cleaves Glutamate Receptor IIA But Not IIB at the Drosophila Neuromuscular Junction.

Authors:  Elsayed Metwally; Guoli Zhao; Wenhua Li; Qifu Wang; Yong Q Zhang
Journal:  J Neurosci       Date:  2019-01-31       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.